Quick Listen: Scrip’s Five Must-Know Things

 
• By Ian Haydock

In this week's episode: a look at JPM; J&J’s Intra-Cellular buy; how JPM Day 1 deals fit into BD strategy; Scrip asks about the global state of biopharma; and what will fuel M&A activity in India this year.

Scrip Five Must Know Things
weekly audio roundup of selected content from Scrip's global team

More from Scrip's Five Must-Know Things

More from Business